We are excited to share insights into a groundbreaking clinical study by the Urological Department of Sapporo Medical University Hospital in Japan, utilizing our Renova treatment protocol.
As low-intensity extracorporeal shock wave technology (Li-ESWT) continues to demonstrate its effectiveness, interest in its remarkable effects on the body is rapidly increasing. We are proud to contribute to this innovative field with a study that is the first of its kind.
Highlights of the Study:
Renova employs Li-ESWT to promote angiogenesis and improve blood flow in the penis, offering a promising, non-invasive treatment for erectile dysfunction (ED). This study aims to investigate the histological effects of Li-ESWT on the corpus cavernosum, involving volunteers undergoing penile resection due to gender identity disorder. We believe these findings will significantly enhance our understanding of angiogenesis and its clinical applications.
We remain committed to supporting cutting-edge research and driving the development of non-invasive medical solutions to improve patient care.
